Cargando…
Cardiac Imaging Biomarkers in Chronic Kidney Disease
Uremic cardiomyopathy (UC), the peculiar cardiac remodeling secondary to the systemic effects of renal dysfunction, is characterized by left ventricular (LV) diffuse fibrosis with hypertrophy (LVH) and stiffness and the development of heart failure and increased rates of cardiovascular mortality. Se...
Autores principales: | Valbuena-López, Silvia C., Camastra, Giovanni, Cacciotti, Luca, Nagel, Eike, Puntmann, Valentina O., Arcari, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216582/ https://www.ncbi.nlm.nih.gov/pubmed/37238643 http://dx.doi.org/10.3390/biom13050773 |
Ejemplares similares
-
Cardiac biomarkers in chronic kidney disease are independently associated with myocardial edema and diffuse fibrosis by cardiovascular magnetic resonance
por: Arcari, Luca, et al.
Publicado: (2021) -
T(1) and T(2) Mapping in Uremic Cardiomyopathy: An Update
por: Arcari, Luca, et al.
Publicado: (2022) -
Heart and Lung Fibrosis in a Patient with COVID-19-Related Myocarditis
por: Camastra, Giovanni, et al.
Publicado: (2022) -
Cardiac Magnetic Resonance Imaging in Immune Check-Point Inhibitor Myocarditis: A Systematic Review
por: Arcari, Luca, et al.
Publicado: (2022) -
Characterization of COVID-19-Related Lung Involvement in Patients Undergoing Magnetic Resonance T1 and T2 Mapping Imaging: A Pilot Study
por: Camastra, Giovanni, et al.
Publicado: (2022)